Neurotrophins and acupuncture

Autonomic Neuroscience: Basic and Clinical

Volumn 157, Issue 1-2, 2010, Pages 9-17

  Manni, Luigi ^a   Albanesi, Marcello ^b   Guaragna, Morena ^b   Barbaro Paparo, Samuele ^b   Aloe, Luigi ^a  

^a CNR   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Acupuncture; Nerve growth factor; Neurotrophin

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; NERVE GROWTH FACTOR;

ACUPUNCTURE; ARTICLE; CELL REGENERATION; CHINESE MEDICINE; CLINICAL TRIAL; EXERCISE; HUMAN; INFLAMMATION; MASSAGE; MOOD DISORDER; MOTOR DYSFUNCTION; NERVE CELL PLASTICITY; NERVE DEGENERATION; NERVE INJURY; NONHUMAN; PAIN; PRIORITY JOURNAL; SEIZURE; SENSORY NERVE CELL;

ACUPUNCTURE; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; HUMANS; INFLAMMATION; MOOD DISORDERS; NERVE GROWTH FACTORS; NERVOUS SYSTEM; PAIN; SEIZURES;

EID: 77957858905     PISSN: 15660702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autneu.2010.03.020     Document Type: Article

References (148)

1. Aarts M.M., Tymianski M. TRPM7 and ischemic CNS injury. Neuroscientist 2005, 11:116-123.
2. Allen S.J., Dawbarn D. Clinical relevance of the neurotrophins and their receptors. Clin. Sci. (Lond.) 2006, 110:175-191.
3. Alleva E., Aloe L., Bigi S. An updated role for nerve growth factor in neurobehavioural regulation of adult vertebrates. Rev. Neurosci. 1993, 4:41-62.
4. Aloe L. Nerve growth factor and neuroimmune responses: basic and clinical observations. Arch. Physiol. Biochem. 2001, 109:354-356.
5. Aloe L. Nerve growth factor, human skin ulcers and vascularization. Our experience. Prog. Brain Res. 2004, 146:515-522.
6. Aloe L., Manni L. Low-frequency electro-acupuncture reduces the nociceptive response and the pain mediator enhancement induced by nerve growth factor. Neurosci. Lett. 2009, 449:173-177.
7. Aloe L., Tirassa P., Alleva E. Cold water swimming stress alters NGF and low-affinity NGF receptor distribution in developing rat brain. Brain Res. Bull. 1994, 33:173-178.
8. Aloe L., Bracci-Laudiero L., Bonini S., Manni L. The expanding role of nerve growth factor: from neurotrophic activity to immunologic diseases. Allergy 1997, 52:883-894.
9. Aloe L., Simone M.D., Properzi F. Nerve growth factor: a neurotrophin with activity on cells of the immune system. Microsc. Res. Tech. 1999, 45:285-291.
10. Aloe L., Alleva E., Fiore M. Stress and nerve growth factor: findings in animal models and humans. Pharmacol. Biochem. Behav. 2002, 73:159-166.
11. Aloe L., Tirassa P., Lambiase A. The topical application of nerve growth factor as a pharmacological tool for human corneal and skin ulcers. Pharmacol. Res. 2008, 57:253-258.
12. Andersson S., Lundeberg T. Acupuncture-from empiricism to science: functional background to acupuncture effects in pain and disease. Med. Hypotheses 1995, 45:271-281.
13. Angelucci F., Mathe A.A., Aloe L. Brain-derived neurotrophic factor and tyrosine kinase receptor TrkB in rat brain are significantly altered after haloperidol and risperidone administration. J Neurosci Res 2000, 60:783-794.
14. Apfel S.C. Nerve growth factor for the treatment of diabetic neuropathy: what went wrong, what went right, and what does the future hold?. Int. Rev. Neurobiol. 2002, 50:393-413.
15. Apfel S.C., Kessler J.A. Neurotrophic factors in the therapy of peripheral neuropathy. Baillieres Clin. Neurol. 1995, 4:593-606.
16. Apfel S.C., Kessler J.A., Adornato B.T., Litchy W.J., Sanders C., Rask C.A. Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. NGF Study Group [see comments]. Neurology 1998, 51:695-702.
17. Apfel S.C., Schwartz S., Adornato B.T., Freeman R., Biton V., Rendell M., Vinik A., Giuliani M., Stevens J.C., Barbano R., Dyck P.J. Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: a randomized controlled trial. rhNGF Clinical Investigator Group. JAMA 2000, 284:2215-2221.
18. Bai Y.H., Lim S.C., Song C.H., Bae C.S., Jin C.S., Choi B.C., Jang C.H., Lee S.H., Pak S.C. Electro-acupuncture reverses nerve growth factor abundance in experimental polycystic ovaries in the rat. Gynecol. Obstet. Invest. 2004, 57:80-85.
19. Barria A., Leyton V., Ojeda S.R., Lara H.E. Ovarian steroidal response to gonadotropins and beta-adrenergic stimulation is enhanced in polycystic ovary syndrome: role of sympathetic innervation. Endocrinology 1993, 133:2696-2703.
20. Bartoletti A., Cancedda L., Reid S.W., Tessarollo L., Porciatti V., Pizzorusso T., Maffei L. Heterozygous knock-out mice for brain-derived neurotrophic factor show a pathway-specific impairment of long-term potentiation but normal critical period for monocular deprivation. J. Neurosci. 2002, 22:10072-10077.
21. Bian J.T., Sun M.Z., Han J.S. Reversal of electroacupuncture tolerance by CCK-8 antiserum: an electrophysiological study on pain-related neurons in nucleus parafascicularis of the rat. Int. J. Neurosci. 1993, 72:15-29.
22. Bonini S., Lambiase A., Bonini S., Levi-Schaffer F., Aloe L. Nerve growth factor: an important molecule in allergic inflammation and tissue remodelling. Int. Arch. Allergy Immunol. 1999, 118:159-162.
23. Bonini S., Lambiase A., Rama P., Caprioglio G., Aloe L. Topical treatment with nerve growth factor for neurotrophic keratitis. Ophthalmology 2000, 107:1347-1351. discussion 1351-1342.
24. Cabioglu M.T., Cetin B.E. Acupuncture and immunomodulation. Am. J. Chin. Med. 2008, 36:25-36.
25. Campbell A. Point specificity of acupuncture in the light of recent clinical and imaging studies. Acupunct. Med. 2006, 24:118-122.
26. Cao X.D., Xu S.F., Lu W.X. Inhibition of sympathetic nervous system by acupuncture. Acupunct. Electrother. Res. 1983, 8:25-35.
27. Capsoni S., Covaceuszach S., Ugolini G., Spirito F., Vignone D., Stefanini B., Amato G., Cattaneo A. Delivery of NGF to the brain: intranasal versus ocular administration in anti-NGF transgenic mice. J. Alzheimers Dis. 2009, 16:371-388.
28. Carlsson C. Acupuncture mechanisms for clinically relevant long-term effects-reconsideration and a hypothesis. Acupunct. Med. 2002, 20:82-99.
29. Chae Y., Hong M.S., Kim G.H., Hahm D.H., Park H.J., Ha E., Kim M.J., Park H.J., Yang J., Lee H. Protein array analysis of cytokine levels on the action of acupuncture in carrageenan-induced inflammation. Neurol. Res. 2007, 29(Suppl 1):S55-58.
30. Chalazonitis A. Neurotrophin-3 in the development of the enteric nervous system. Prog. Brain Res. 2004, 146:243-263.
31. Chao D.M., Shen L.L., Tjen A.L.S., Pitsillides K.F., Li P., Longhurst J.C. Naloxone reverses inhibitory effect of electroacupuncture on sympathetic cardiovascular reflex responses. Am. J. Physiol. 1999, 276:H2127-2134.
32. Chao M.V., Rajagopal R., Lee F.S. Neurotrophin signalling in health and disease. Clin. Sci. (Lond.) 2006, 110:167-173.
33. Chen X.Q., Fawcett J.R., Rahman Y.E., Ala T.A., Frey I.W. Delivery of nerve growth factor to the brain via the olfactory pathway. J. Alzheimers Dis. 1998, 1:35-44.
34. Chen J., Qi J.G., Zhang W., Zhou X., Meng Q.S., Zhang W.M., Wang X.Y., Wang T.H. Electro-acupuncture induced NGF, BDNF and NT-3 expression in spared L6 dorsal root ganglion in cats subjected to removal of adjacent ganglia. Neurosci. Res. 2007, 59:399-405.
35. Chen Y.Y., Zhang W., Chen Y.L., Chen S.J., Dong H., Zeng Y.S. Electro-acupuncture improves survival and migration of transplanted neural stem cells in injured spinal cord in rats. Acupunct. Electrother. Res. 2008, 33:19-31.
36. Chiaretti A., Genovese O., Riccardi R., Di Rocco C., Di Giuda D., Mariotti P., Pulitano S., Piastra M., Polidori G., Colafati G.S., Aloe L. Intraventricular nerve growth factor infusion: a possible treatment for neurological deficits following hypoxic-ischemic brain injury in infants. Neurol. Res. 2005, 27:741-746.
37. Colangelo A.M., Mallei A., Johnson P.F., Mocchetti I. Synergistic effect of dexamethasone and beta-adrenergic receptor agonists on the nerve growth factor gene transcription. Brain Res. Mol. Brain Res. 2004, 124:97-104.
38. Connor B., Dragunow M. The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res. Brain Res. Rev. 1998, 27:1-39.
39. Cowan W.M. Viktor Hamburger and Rita Levi-Montalcini: the path to the discovery of nerve growth factor. Annu. Rev. Neurosci. 2001, 24:551-600.
40. Culmsee C., Stumm R.K., Schafer M.K., Weihe E., Krieglstein J. Clenbuterol induces growth factor mRNA, activates astrocytes, and protects rat brain tissue against ischemic damage. Eur. J. Pharmacol. 1999, 379:33-45.
41. Day-Lollini P.A., Stewart G.R., Taylor M.J., Johnson R.M., Chellman G.J. Hyperplastic changes within the leptomeninges of the rat and monkey in response to chronic intracerebroventricular infusion of nerve growth factor. Exp. Neurol. 1997, 145:24-37.
42. Ding Y., Yan Q., Ruan J.W., Zhang Y.Q., Li W.J., Zhang Y.J., Li Y., Dong H., Zeng Y.S. Electro-acupuncture promotes survival, differentiation of the bone marrow mesenchymal stem cells as well as functional recovery in the spinal cord-transected rats. BMC Neurosci. 2009, 10:35.
43. Duman R.S., Monteggia L.M. A neurotrophic model for stress-related mood disorders. Biol. Psychiatry 2006, 59:1116-1127.
44. Eriksdotter Jonhagen M., Nordberg A., Amberla K., Backman L., Ebendal T., Meyerson B., Olson L., Seiger Shigeta M., Theodorsson E., Viitanen M., Winblad B., Wahlund L.O. Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 1998, 9:246-257.
45. Ernfors P. Local and target-derived actions of neurotrophins during peripheral nervous system development. Cell. Mol. Life Sci. 2001, 58:1036-1044.
46. Ernfors P., Wetmore C., Olson L., Persson H. Identification of cells in rat brain and peripheral tissues expressing mRNA for members of the nerve growth factor family. Neuron 1990, 5:511-526.
47. Friedman W.J., Greene L.A. Neurotrophin signaling via Trks and p75. Exp. Cell Res. 1999, 253:131-142.
48. Friedman W.J., Ibanez C.F., Hallbook F., Persson H., Cain L.D., Dreyfus C.F., Black I.B. Differential actions of neurotrophins in the locus coeruleus and basal forebrain. Exp. Neurol. 1993, 119:72-78.
49. Friedman W.J., Black I.B., Kaplan D.R. Distribution of the neurotrophins brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4/5 in the postnatal rat brain: an immunocytochemical study. Neuroscience 1998, 84:101-114.
50. Funakoshi H., Belluardo N., Arenas E., Yamamoto Y., Casabona A., Persson H., Ibanez C.F. Muscle-derived neurotrophin-4 as an activity-dependent trophic signal for adult motor neurons. Science 1995, 268:1495-1499.
51. Generini S., Tuveri M.A., Matucci Cerinic M., Mastinu F., Manni L., Aloe L. Topical application of nerve growth factor in human diabetic foot ulcers. A study of three cases. Exp. Clin. Endocrinol. Diabetes 2004, 112:542-544.
52. Guo H.-F., Tian J., Wang X., Fang Y., Yueping H., Jisheng H. Brain substrates activted by electroacupuncture of different frequencies (1): comparative study on the expression of oncogene c-fos and genes coding for three opioid peptides. Mol. Brain Res. 1996, 43:157-166.
53. Hallbook F., Ibanez C.F., Persson H. Evolutionary studies of the nerve growth factor family reveal a novel member abundantly expressed in Xenopus ovary. Neuron 1991, 6:845-858.
54. Han J.S., Ding X.Z., Fan S.G. Cholecystokinin octapeptide (CCK-8): antagonism to electroacupuncture analgesia and a possible role in electroacupuncture tolerance. Pain 1986, 27:101-115.
55. He L., Wang M., Gao M., Zhou J. Expression of c-fos protein in serotonergic neurons of rat brainstem following electro-acupuncture. Acupunct. Electrother. Res. 1992, 17:243-248.
56. Hefti F.F., Rosenthal A., Walicke P.A., Wyatt S., Vergara G., Shelton D.L., Davies A.M. Novel class of pain drugs based on antagonism of NGF. Trends Pharmacol. Sci. 2006, 27:85-91.
57. Hochhaus F., Koehne P., Schaper C., Butenandt O., Felderhoff-Mueser U., Ring-Mrozik E., Obladen M., Buhrer C. Elevated nerve growth factor and neurotrophin-3 levels in cerebrospinal fluid of children with hydrocephalus. BMC Pediatr. 2001, 1:2.
58. Holden J.E., Jeong Y., Forrest J.M. The endogenous opioid system and clinical pain management. AACN Clin. Issues 2005, 16:291-301.
59. Hole K., Berge O.G. Regulation of pain sensitivity in the central nervous system. Cephalalgia 1981, 1:51-59.
60. Huang E.J., Reichardt L.F. TRK receptors: roles in neuronal signal transduction 2003, vol. 72:609-642.
61. Hui K.K., Liu J., Makris N., Gollub R.L., Chen A.J., Moore C.I., Kennedy D.N., Rosen B.R., Kwong K.K. Acupuncture modulates the limbic system and subcortical gray structures of the human brain: evidence from fMRI studies in normal subjects. Hum. Brain Mapp. 2000, 9:13-25.
62. Ibanez C.F. Neurotrophin-4: the odd one out in the neurotrophin family. Neurochem. Res. 1996, 21:787-793.
63. Ip N.Y., Ibanez C.F., Nye S.H., McClain J., Jones P.F., Gies D.R., Belluscio L., Le Beau M.M., Espinosa R., Squinto S.P., et al. Mammalian neurotrophin-4: structure, chromosomal localization, tissue distribution, and receptor specificity. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:3060-3064.
64. Kaptchuk T.J. Acupuncture: theory, efficacy, and practice. Ann. Intern. Med. 2002, 136:374-383.
65. Kaufman M.P., Waldrop T.G., Rybycki K.J., Ordway G.A., Mitchell J.H. Effects of static and rhythmic twitch contractions on the discharge of group III and IV muscle afferents. Cardiovasc. Res. 1984, 18:663-668.
66. Kawakita K. Role of polymodal receptors in the peripheral mechanisms of acupuncture and moxibusition stimulation. Advances in Physiology Science, New Dehli 1991, 731-739. S.K. Manchanda, W. Selvamurthy, V. Mohan Kumar (Eds.).
67. Kawakita K., Gotoh K. Role of polymodal receptors in the acupuncture-mediated endogenous pain inhibitory systems. Prog. Brain Res. 1996, 113:507-523.
68. Kawakita K., Shinbara H., Imai K., Fukuda F., Yano T., Kuriyama K. How do acupuncture and moxibustion act? Focusing on the progress in Japanese acupuncture research. J. Pharmacol. Sci. 2006, 100:443-459.
69. Kennedy A.J., Wellmer A., Facer P., Saldanha G., Kopelman P., Lindsay R.M., Anand P. Neurotrophin-3 is increased in skin in human diabetic neuropathy. J. Neurol. Neurosurg. Psychiatry 1998, 65:393-395.
70. Kim W.S., Kim I.S., Kim S.J., Wei P., Hyung Choi D., Han T.R. Effect of electroacupuncture on motor recovery in a rat stroke model during the early recovery stage. Brain Res. 2009, 1248:176-183.
71. Klesse L.J., Parada L.F. Trks: signal transduction and intracellular pathways. Microsc. Res. Tech. 1999, 45:210-216.
72. Kniffki K.D., Mense S., Schmidt R.F. Muscle receptors with fine afferent fibers which may evoke circulatory reflexes. Circ. Res. 1981, 48:125-131.
73. Koliatsos V.E., Clatterbuck R.E., Nauta H.J., Knusel B., Burton L.E., Hefti F.F., Mobley W.C., Price D.L. Human nerve growth factor prevents degeneration of basal forebrain cholinergic neurons in primates. Ann. Neurol. 1991, 30:831-840.
74. Krzan M., Wu V.W., Schwartz J.P. Serotonin regulation of nerve growth factor synthesis in neonatal and adult astrocytes: comparison to the beta-adrenergic agonist isoproterenol. J Neurosci Res 2001, 64:261-267.
75. Kwon Y.B., Kang M.S., Son S.S., Kim J.T., Lee Y.H., Han H.J., Lee J.H. Different frequencies of electroacupuncture modified the cellular activity of serotonergic neurons in brainstem. Am. J. Chin. Med. 2000, 28:435-441.
76. Lambiase A., Manni L., Bonini S., Rama P., Micera A., Aloe L. Nerve growth factor promotes corneal healing: structural, biochemical, and molecular analyses of rat and human corneas. Invest. Ophthalmol. Vis. Sci. 2000, 41:1063-1069.
77. Lambiase A., Manni L., Rama P., Bonini S. Clinical application of nerve growth factor on human corneal ulcer. Arch. Ital. Biol. 2003, 141:141-148.
78. Lambiase A., Pagani L., Di Fausto V., Sposato V., Coassin M., Bonini S., Aloe L. Nerve growth factor eye drop administrated on the ocular surface of rodents affects the nucleus basalis and septum: biochemical and structural evidence. Brain Res. 2007, 1127:45-51.
79. Lara H.E., Ferruz J.L., Luza S., Bustamante D.A., Borges Y., Ojeda S.R. Activation of ovarian sympathetic nerves in polycystic ovary syndrome. Endocrinology 1993, 133:2690-2695.
80. Lara H.E., Dissen G.A., Leyton V., Paredes A., Fuenzalida H., Fiedler J.L., Ojeda S.R. An increased intraovarian synthesis of nerve growth factor and its low affinity receptor is a principal component of steroid-induced polycystic ovary in the rat. Endocrinology 2000, 141:1059-1072.
81. Lara H.E., Dorfman M., Venegas M., Luza S.M., Luna S.L., Mayerhofer A., Guimaraes M.A., Rosa E Silva A.A.M., Ramírez V.D. Changes in sympathetic nerve activity of the mammalian ovary during a normal estrous cycle and in polycystic ovary syndrome: studies in norepinephrine release. Microsc. Res. Tech. 2002, 59:495-502.
82. Lee E., Son H. Adult hippocampal neurogenesis and related neurotrophic factors. BMB Reports 2009, 42:239-244.
83. Lewin G.R., Barde Y.A. Physiology of the neurotrophins. Annu. Rev. Neurosci. 1996, 19:289-317.
84. Liang X.B., Liu X.Y., Li F.Q., Luo Y., Lu J., Zhang W.M., Wang X.M., Han J.S. Long-term high-frequency electro-acupuncture stimulation prevents neuronal degeneration and up-regulates BDNF mRNA in the substantia nigra and ventral tegmental area following medial forebrain bundle axotomy. Brain Res. Mol. Brain Res. 2002, 108:51-59.
85. Lindsay R.M. Role of neurotrophins and trk receptors in the development and maintenance of sensory neurons: an overview. Philos. Trans. R. Soc. Lond. B Biol. Sci. 1996, 351:365-373.
86. Liu F., Sun W.W., Wang Y., Hu L.Q., Dai P., Tian C.F., Wang T.H. Effects of electro-acupuncture on NT-4 expression in spinal dorsal root ganglion and associated segments of the spinal dorsal horn in cats subjected to adjacent dorsal root ganglionectomy. Neurosci. Lett. 2009, 450:158-162.
87. Lu B., Gottschalk W. Modulation of hippocampal synaptic transmission and plasticity by neurotrophins. Prog. Brain Res. 2000, 128:231-241.
88. Maestripieri D., De Simone R., Aloe L., Alleva E. Social status and nerve growth factor serum levels after agonistic encounters in mice. Physiol. Behav. 1990, 47:161-164.
89. Maisonpierre P.C., Belluscio L., Squinto S., Ip N.Y., Furth M.E., Lindsay R.M., Yancopoulos G.D. Neurotrophin-3: a neurotrophic factor related to NGF and BDNF. Science 1990, 247:1446-1451.
90. Manneras L., Jonsdottir I.H., Holmang A., Lonn M., Stener-Victorin E. Low-frequency electro-acupuncture and physical exercise improve metabolic disturbances and modulate gene expression in adipose tissue in rats with dihydrotestosterone-induced polycystic ovary syndrome. Endocrinology 2008, 149:3559-3568.
91. Manneras L., Cajander S., Lonn M., Stener-Victorin E. Acupuncture and exercise restore adipose tissue expression of sympathetic markers and improve ovarian morphology in rats with dihydrotestosterone-induced PCOS. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 926:R1124-R1131.
92. Manni L., Lundeberg T., Tirassa P., Aloe L. Cholecystokinin-8 enhances nerve growth factor synthesis and promotes recovery of capsaicin-induced sensory deficit. Br. J. Pharmacol. 2000, 129:744-750.
93. Manni L., Aloe L., Tirassa P., Finn A., Lundeberg T. Cholecystokinin-8 promotes recovery of sympathectomy induced by 6-hydroxydopamine in adult mice. NeuroReport 2001, 12:1621-1627.
94. Manni L., Lundeberg T., Tirassa P., Aloe L. Role of cholecystokinin-8 in nerve growth factor and nerve growth factor mRNA expression in carrageenan-induced joint inflammation in adult rats. Rheumatology (Oxford) 2002, 41:787-792.
95. Manni L., Cajander S., Lundeberg T., Naylor A.S., Aloe L., Holmang A., Jonsdottir I.H., Stener-Victorin E. Effect of exercise on ovarian morphology and expression of nerve growth factor and alpha(1)- and beta(2)-adrenergic receptors in rats with steroid- induced polycystic ovaries. J. Neuroendocrinol. 2005, 17:846-858.
96. Manni L., Holmang A., Lundeberg T., Aloe L., Stener- Victorin E. Ovarian expression of alpha (1)- and beta (2)- adrenoceptors and p75 neurotrophin receptors in rats with steroid- induced polycystic ovaries. Auton Neurosci 2005, 118:79-87.
97. Manni L., Lundeberg T., Holmang A., Aloe L., Stener- Victorin E. Effect of electro-acupuncture on ovarian expression of alpha (1)- and beta (2)-adrenoceptors, and p75 neurotrophin receptors in rats with steroid-induced polycystic ovaries. Reprod. Biol. Endocrinol. 2005, 3:21.
98. Manni L., Holmang A., Cajander S., Lundeberg T., Aloe L., Stener-Victorin E. Effect of anti-NGF on ovarian expression of alpha1- and beta2-adrenoceptors, TrkA, p75NTR, and tyrosine hydroxylase in rats with steroid-induced polycystic ovaries. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006, 290:R826-835.
99. McAllister A.K. Neurotrophins and neuronal differentiation in the central nervous system. Cell. Mol. Life Sci. 2001, 58:1054-1060.
100. McArthur J.C., Yiannoutsos C., Simpson D.M., Adornato B.T., Singer E.J., Hollander H., Marra C., Rubin M., Cohen B.A., Tucker T., Navia B.A., Schifitto G., Katzenstein D., Rask C., Zaborski L., Smith M.E., Shriver S., Millar L., Clifford D.B., Karalnik I.J. see comments] [published erratum appears in Neurology 2000 Jul 13;55(1):162. Neurology 2000, 54:1080-1088.
101. Miller F.D., Kaplan D.R. Neurotrophin signalling pathways regulating neuronal apoptosis. Cell. Mol. Life Sci. 2001, 58:1045-1053.
102. Mufson E.J., Kroin J.S., Sendera T.J., Sobreviela T. Distribution and retrograde transport of trophic factors in the central nervous system: functional implications for the treatment of neurodegenerative diseases. Prog. Neurobiol. 1999, 57:451-484.
103. Olson L. NGF and the treatment of Alzheimer's disease. Exp. Neurol. 1993, 124:5-15.
104. Olson L. Reparative strategies in the brain: treatment strategies based on trophic factors and cell transfer techniques. Acta Neurochir Suppl (Wien) 1993, 58:3-7.
105. Pagani L., Manni L., Aloe L. Effects of electroacupuncture on retinal nerve growth factor and brain-derived neurotrophic factor expression in a rat model of retinitis pigmentosa. Brain Res. 2006, 1092:198-206.
106. Parkman H.P., Rao S.S., Reynolds J.C., Schiller L.R., Wald A., Miner P.B., Lembo A.J., Gordon J.M., Drossman D.A., Waltzman L., Stambler N., Cedarbaum J.M. Neurotrophin-3 improves functional constipation. Am. J. Gastroenterol. 2003, 98:1338-1347.
107. Pezet S., Malcangio M. Brain-derived neurotrophic factor as a drug target for CNS disorders. Expert Opin Ther. Targets 2004, 8:391-399.
108. Poo M.M. Neurotrophins as synaptic modulators. Nat Rev Neurosci 2001, 2:24-32.
109. Reichardt L.F. Neurotrophin-regulated signalling pathways. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2006, 361:1545-1564.
110. Rush R.A., Chie E., Liu D., Tafreshi A., Zettler C., Zhou X.F. Neurotrophic factors are required by mature sympathetic neurons for survival, transmission and connectivity. Clin. Exp. Pharmacol. Physiol. 1997, 24:549-555.
111. Sahenk Z., Nagaraja H.N., McCracken B.S., King W.M., Freimer M.L., Cedarbaum J.M., Mendell J.R. NT-3 promotes nerve regeneration and sensory improvement in CMT1A mouse models and in patients. Neurology 2005, 65:681-689.
112. Samina Riaz S., Tomlinson D.R. Pharmacological modulation of nerve growth factor synthesis: a mechanistic comparison of vitamin D receptor and beta(2)-adrenoceptor agonists. Brain Res. Mol. Brain Res. 2000, 85:179-188.
113. Schaaf M.J., De Kloet E.R., Vreugdenhil E. Corticosterone effects on BDNF expression in the hippocampus. Implications for memory formation. Stress (Amsterdam, Netherlands) 2000, 3:201-208.
114. Schor N.F. The p75 neurotrophin receptor in human development and disease. Prog. Neurobiol. 2005, 77:201-214.
115. Schulte-Herbruggen O., Braun A., Rochlitzer S., Jockers-Scherubl M.C., Hellweg R. Neurotrophic factors-a tool for therapeutic strategies in neurological, neuropsychiatric and neuroimmunological diseases?. Curr. Med. Chem. 2007, 14:2318-2329.
116. Seiger A., Nordberg A., von Holst H., Backman L., Ebendal T., Alafuzoff I., Amberla K., Hartvig P., Herlitz A., Lilja A., et al. Intracranial infusion of purified nerve growth factor to an Alzheimer patient: the first attempt of a possible future treatment strategy. Behav. Brain Res. 1993, 57:255-261.
117. Semkova I., Schilling M., Henrich-Noack P., Rami A., Krieglstein J. Clenbuterol protects mouse cerebral cortex and rat hippocampus from ischemic damage and attenuates glutamate neurotoxicity in cultured hippocampal neurons by induction of NGF. Brain Res. 1996, 717:44-54.
118. Skup M.H. BDNF and NT-3 widen the scope of neurotrophin activity: pharmacological implications. Acta Neurobiol. Exp. 1994, 54:81-94.
119. Stener-Victorin E., Lundeberg T., Waldenstrom U., Manni L., Aloe L., Gunnarsson S., Janson P.O. Effects of electro-acupuncture on nerve growth factor and ovarian morphology in rats with experimentally induced polycystic ovaries. Biol. Reprod. 2000, 63:1497-1503.
120. Stener-Victorin E., Lundeberg T., Cajander S., Aloe L., Manni L., Waldenstrom U., Janson P.O. Steroid-induced polycystic ovaries in rats: effect of electro-acupuncture on concentrations of endothelin-1 and nerve growth factor (NGF), and expression of NGF mRNA in the ovaries, the adrenal glands, and the central nervous system. Reprod. Biol. Endocrinol. 2003, 1:33.
121. Sun N., Zou X., Shi J., Liu X., Li L., Zhao L. Electroacupuncture regulates NMDA receptor NR1 subunit expression via PI3-K pathway in a rat model of cerebral ischemia-reperfusion. Brain Res. 2005, 1064:98-107.
122. Taglialatela G., Angelucci L., Scaccianoce S., Foreman P.J., Perez-Polo J.R. Nerve growth factor modulates the activation of the hypothalamo-pituitary-adrenocortical axis during the stress response. Endocrinology 1991, 129(129):2212-2218.
123. Takagi J., Yonehara N. Serotonin receptor subtypes involved in modulation of electrical acupuncture. Jpn. J. Pharmacol. 1998, 78(4):511-514.
124. Terenghi G. Peripheral nerve regeneration and neurotrophic factors. J. Anat. 1999, 194(Pt 1):1-14. 194.
125. Thorne R.G., Frey W.H. Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations. Clin. Pharmacokinet. 2001, 40:907-946.
126. Tirassa P., Stenfors C., Lundeberg T., Aloe L. Cholecystokinin-8 regulation of NGF concentrations in adult mouse brain through a mechanism involving CCK(A) and CCK(B) receptors. Br. J. Pharmacol. 1998, 123:1230-1236.
127. Tirassa P., Aloe L., Stenfors C., Turrini P., Lundeberg T. Cholecystokinin-8 protects central cholinergic neurons against fimbria-fornix lesion through the up-regulation of nerve growth factor synthesis. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:6473-6477.
128. Tuszynski M.H., Thal L., Pay M., Salmon D.P., U, H.S., Bakay R., Patel P., Blesch A., Vahlsing H.L., Ho G., Tong G., Potkin S.G., Fallon J., Hansen L., Mufson E.J., Kordower J.H., Gall C., Conner J. A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat. Med. 2005, 11:551-555.
129. Tuveri M., Generini S., Matucci-Cerinic M., Aloe L. NGF, a useful tool in the treatment of chronic vasculitic ulcers in rheumatoid arthritis. Lancet 2000, 356:1739-1740.
130. Ulett G.A., Han S., Han J.S. Electroacupuncture: mechanisms and clinical application. Biol. Psychiatry 1998, 44:129-138.
131. Vassilakopoulos T., Roussos C., Zakynthinos S. Is loaded breathing an inflammatory stimulus?. Curr. Opin. Crit. Care 2005, 11:1-9.
132. Vitalis T., Cases O., Gillies K., Hanoun N., Hamon M., Seif I., Gaspar P., Kind P., Price D.J. Interactions between TrkB signaling and serotonin excess in the developing murine somatosensory cortex: a role in tangential and radial organization of thalamocortical axons. J. Neurosci. 2002, 22:4987-5000.
133. Wang T.H., Wang X.Y., Li X.L., Chen H.M., Wu L.F. Effect of electroacupuncture on neurotrophin expression in cat spinal cord after partial dorsal rhizotomy. Neurochem. Res. 2007, 32:1415-1422.
134. Winkler J., Ramirez G.A., Kuhn H.G., Peterson D.A., Day-Lollini P.A., Stewart G.R., Tuszynski M.H., Gage F.H., Thal L.J. Reversible Schwann cell hyperplasia and sprouting of sensory and sympathetic neurites after intraventricular administration of nerve growth factor. Ann. Neurol. 1997, 41:82-93.
135. Wu M.T., Hsieh J.C., Xiong J., Yang C.F., Pan H.B., Chen Y.C., Tsai G., Rosen B.R., Kwong K.K. Central nervous pathway for acupuncture stimulation: localization of processing with functional MR imaging of the brain-preliminary experience. Radiology 1999, 212:133-141.
136. Wu H.G., Jiang B., Zhou E.H., Shi Z., Shi D.R., Cui Y.H., Kou S.T., Liu H.R. Regulatory mechanism of electroacupuncture in irritable bowel syndrome: preventing MC activation and decreasing SP VIP secretion. Dig. Dis. Sci. 2008, 53:1644-1651.
137. Xing G.G., Liu F.Y., Qu X.X., Han J.S., Wan Y. Long-term synaptic plasticity in the spinal dorsal horn and its modulation by electroacupuncture in rats with neuropathic pain. Exp. Neurol. 2007, 208:323-332.
138. Yamada K., Nabeshima T. Brain-derived neurotrophic factor/TrkB signaling in memory processes. J. Pharmacol. Sci. 2003, 91:267-270.
139. Yamada K., Mizuno M., Nabeshima T. Role for brain-derived neurotrophic factor in learning and memory. Life Sci. 2002, 70:735-744.
140. Yasuno H., Fukazawa K., Fukuoka T., Kondo E., Sakagami M., Noguchi K. Nerve growth factor applied onto the olfactory epithelium alleviates degenerative changes of the olfactory receptor neurons following axotomy. Brain Res. 2000, 887:53-62.
141. Yun S.J., Park H.J., Yeom M.J., Hahm D.H., Lee H.J., Lee E.H. Effect of electroacupuncture on the stress-induced changes in brain-derived neurotrophic factor expression in rat hippocampus. Neurosci. Lett. 2002, 318:85-88.
142. Zhang W.T., Jin Z., Luo F., Zhang L., Zeng Y.W., Han J.S. Evidence from brain imaging with fMRI supporting functional specificity of acupoints in humans. Neurosci. Lett. 2004, 354:50-53.
143. Zhang D., Ding G., Shen X., Yao W., Zhang Z., Zhang Y., Lin J., Gu Q. Role of mast cells in acupuncture effect: a pilot study. Explore (New York, N.Y) 2008, 4:170-177.
144. Zhao Z.Q. Neural mechanism underlying acupuncture analgesia. Prog. Neurobiol. 2008, 85:355-375.
145. Zhao, L., Shi, J., Sun, N., Tian, S., Meng, X., Liu, X., Li, L. 2005. Effect of electroacupuncture on TRPM7 mRNA expression after cerebral ischemia/reperfusion in rats via TrkA pathway. Journal of Huazhong University of Science and Technology. Medical sciences=Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban=Huazhong keji daxue xuebao 25, 247-250.
146. Zhao L., Wang Y., Sun N., Liu X., Li L., Shi J. Electroacupuncture regulates TRPM7 expression through the trkA/PI3K pathway after cerebral ischemia-reperfusion in rats. Life Sci. 2007, 81:1211-1222.
147. Zhou X.F., Rush R.A. Localization of neurotrophin-3-like immunoreactivity in the rat central nervous system. Brain Res. 1994, 643:162-172.
148. Zijlstra F.J., van den Berg-de Lange I., Huygen F.J., Klein J. Anti-inflammatory actions of acupuncture. Mediat. Inflamm. 2003, 12:59-69.